TrialEuropean journal of clinical pharmacology2019

Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.

Arash Ghasemi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.